Adam Sharp

6.1k total citations
65 papers, 1.4k citations indexed

About

Adam Sharp is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Adam Sharp has authored 65 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Adam Sharp's work include Prostate Cancer Treatment and Research (23 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Cancer, Lipids, and Metabolism (7 papers). Adam Sharp is often cited by papers focused on Prostate Cancer Treatment and Research (23 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Cancer, Lipids, and Metabolism (7 papers). Adam Sharp collaborates with scholars based in United Kingdom, United States and Spain. Adam Sharp's co-authors include Johann S. de Bono, Graham Packham, Paul A. Townsend, Ramsey Cutress, Matthew Brimmell, Alec Paschalis, D. K. Banerjee, Jonathan Welti, Stephen R. Plymate and Jun Luo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Adam Sharp

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Sharp United Kingdom 23 687 492 363 272 130 65 1.4k
Richard J. Rebello Australia 13 649 0.9× 611 1.2× 317 0.9× 364 1.3× 120 0.9× 18 1.4k
Markku H. Vaarala Finland 22 572 0.8× 552 1.1× 286 0.8× 220 0.8× 238 1.8× 53 1.5k
Martin L. Campbell United States 13 805 1.2× 403 0.8× 515 1.4× 232 0.9× 116 0.9× 18 1.4k
Punit Saraon Canada 19 805 1.2× 240 0.5× 236 0.7× 267 1.0× 152 1.2× 25 1.5k
Mario Monaco Italy 22 565 0.8× 448 0.9× 273 0.8× 241 0.9× 125 1.0× 72 1.6k
Hanna Romańska United Kingdom 21 756 1.1× 397 0.8× 302 0.8× 274 1.0× 113 0.9× 58 1.7k
Tsukasa Igawa Japan 16 481 0.7× 447 0.9× 278 0.8× 191 0.7× 97 0.7× 107 1.2k
Matthew Simms United Kingdom 17 409 0.6× 346 0.7× 271 0.7× 184 0.7× 145 1.1× 41 1.2k
William C. Powell United States 15 804 1.2× 384 0.8× 409 1.1× 430 1.6× 156 1.2× 26 1.4k
Qiong Zou China 22 786 1.1× 235 0.5× 349 1.0× 397 1.5× 125 1.0× 105 1.4k

Countries citing papers authored by Adam Sharp

Since Specialization
Citations

This map shows the geographic impact of Adam Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Sharp more than expected).

Fields of papers citing papers by Adam Sharp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Sharp. The network helps show where Adam Sharp may publish in the future.

Co-authorship network of co-authors of Adam Sharp

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Sharp. A scholar is included among the top collaborators of Adam Sharp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Sharp. Adam Sharp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cimadamore, Alessia, et al.. (2025). Novel Therapeutic Strategies for Metastatic Prostate Cancer Care. European Urology. 88(5). 437–448. 2 indexed citations
2.
Minchom, Anna, et al.. (2025). Treatment-related adverse events of antibody drug-conjugates in clinical trials. Journal of Hematology & Oncology. 18(1). 71–71. 5 indexed citations
3.
Rata, Mihaela, Adam Sharp, Christina Messiou, et al.. (2024). Inter- and Intra-Patient Repeatability of Radiomic Features from Multiparametric Whole-Body MRI in Patients with Metastatic Prostate Cancer. Cancers. 16(9). 1647–1647. 1 indexed citations
4.
Thomas, Christian, Martin Puhr, Wilbert Zwart, et al.. (2024). Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium. Journal of Experimental & Clinical Cancer Research. 43(1). 194–194. 3 indexed citations
5.
Solozobova, Valeria, Nicole Jung, Victor Gourain, et al.. (2023). Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy. Cancer Research Communications. 3(7). 1378–1396. 4 indexed citations
6.
Neeb, Antje, Ines Figueiredo, Bora Gürel, et al.. (2023). Development and Validation of a New BAG-1L–Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer. Laboratory Investigation. 103(11). 100245–100245.
7.
Sheehan, Beshara, Antje Neeb, Lorenzo Buroni, et al.. (2022). Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer. Clinical Cancer Research. 28(14). 3104–3115. 22 indexed citations
8.
Lu, Changxue, Angelika Terbuch, David Dolling, et al.. (2020). Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype. Annals of Oncology. 31(9). 1178–1185. 32 indexed citations
9.
Miyahira, Andrea K., Adam Sharp, Leigh Ellis, et al.. (2019). Prostate cancer research: The next generation; report from the 2019 Coffey‐Holden Prostate Cancer Academy Meeting. The Prostate. 80(2). 113–132. 30 indexed citations
10.
Li, Shangze, Ka-wing Fong, Galina Gritsina, et al.. (2019). Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. Cancer Research. 79(10). 2580–2592. 92 indexed citations
11.
Rodrigues, Daniel Nava, Nicola Casiraghi, Alessandro Romanel, et al.. (2018). RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 25(2). 687–697. 44 indexed citations
12.
Paschalis, Alec, Adam Sharp, Jonathan Welti, et al.. (2018). Alternative splicing in prostate cancer. Nature Reviews Clinical Oncology. 15(11). 663–675. 135 indexed citations
13.
Mehra, Niven, George Seed, Maryou Lambros, et al.. (2016). Myeloid-derived suppressor cells (MDSCs) in metastatic castration-resistant prostate cancer (CRPC) patients (PTS). Annals of Oncology. 27. vi257–vi257. 6 indexed citations
14.
Redana, Stefania, Adam Sharp, Hazel Lote, et al.. (2016). Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population. The Breast. 30. 13–18. 11 indexed citations
15.
Sharp, Adam, Andrew Wotherspoon, Alexandra Léary, et al.. (2015). Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice. BMC Research Notes. 8(1). 688–688. 5 indexed citations
16.
Kumar, Rajiv, Anna Minchom, Adam Sharp, et al.. (2015). A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients. Cancer Chemotherapy and Pharmacology. 77(2). 375–383. 9 indexed citations
17.
Sharp, Adam & Stephen Johnston. (2015). Dose-Reduced Trastuzumab Emtansine: Active and Safe in Acute Hepatic Dysfunction. Case Reports in Oncology. 8(1). 113–121. 5 indexed citations
18.
Douglas, James J., Adam Sharp, Julia E. Head, et al.. (2014). Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract. British Journal of Cancer. 110(7). 1759–1766. 23 indexed citations
19.
Sharp, Adam, Simon J. Crabb, Peter Johnson, et al.. (2009). Thioflavin S (NSC71948) Interferes with Bcl-2-Associated Athanogene (BAG-1)-Mediated Protein-Protein Interactions. Journal of Pharmacology and Experimental Therapeutics. 331(2). 680–689. 26 indexed citations
20.
Serra, Iván, et al.. (1986). Epidemiologia del cancer biliar en chile. Analisis preliminar. 27(2). 63–73. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard J. Rebello Breakdown of academic impact, for papers by Markku H. Vaarala Breakdown of academic impact, for papers by Martin L. Campbell Breakdown of academic impact, for papers by Punit Saraon Breakdown of academic impact, for papers by Mario Monaco Breakdown of academic impact, for papers by Hanna Romańska Breakdown of academic impact, for papers by Tsukasa Igawa Breakdown of academic impact, for papers by Matthew Simms Breakdown of academic impact, for papers by William C. Powell Breakdown of academic impact, for papers by Qiong Zou
Rankless by CCL
2026